chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: intense itching of toes enough to wake up from sleep; Rash on tops on toes and upper part of foot; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 20Apr2021 at 16:00 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included fexofenadine hydrochloride/pseudoephedrine hydrochloride (ALLEGRA D 12HR), ascorbic acid/ pyridoxine hydrochloride/ biotin/  tocopheryl acetate/ folic acid/ thiamine/ nicotinic acid/ colecalciferol/ cyanocobalamin/ retinol/ pantothenic acid/ riboflavin/ phytomenadione/ iron/ sodium/  copper/ zinc/ calcium/ iodine (FLINTSTONES COMPLETE) and malus spp. vinegar extract (APPLE CIDER VINEGAR) ACV Gummies; all for unknown indications from unknown dates and unknown if ongoing. On 25Apr2021 at 18:00, the patient experienced intense itching of toes enough to wake up from sleep and rash on tops on toes and upper part of foot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense itching of toes enough to wake up from sleep and rash on tops on toes and upper part of foot was not resolved at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lymphadenopathy, Migraine, Nausea, Neuralgia
Clinical narrative: Swollen tonsils; Swollen neck lymph nodes; Sore throat; Migraines; Nerve pain; Hard bump at injection site; Fatigue; Vertigo; Nausea; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Apr2021 at 14:00 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. The medical history included fibromyalgia, migraines, allergy to shellfish, wasp and bee stings, and latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included AMOXICILLIN, SINGULAIR, MELATONIN, MEDROL, and IODINE, all from unknown dates for unknown indications and unknown if ongoing. The patient previously took LAMICTAL and LATUDA on unknown dates and experienced allergy. On 23Apr2021 at 14:30, the patient experienced swollen tonsils, swollen neck lymph nodes, sore throat, migraines, nerve pain, hard bump at injection site, fatigue, vertigo, nausea, and vomiting. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination the patient had not been tested for COVID-19. The clinical outcome of the events swollen tonsils, swollen neck lymph nodes, sore throat, migraines, nerve pain, hard bump at injection site, fatigue, vertigo, nausea, and vomiting were not resolved at the time of this report.    No follow-up attempts are required, information about lot/batch number cannot be obtained. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Tonsillar hypertrophy, Vaccination site mass, Vertigo, Vomiting
Clinical narrative: Swollen tonsils; Swollen neck lymph nodes; Sore throat; Migraines; Nerve pain; Hard bump at injection site; Fatigue; Vertigo; Nausea; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Apr2021 at 14:00 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. The medical history included fibromyalgia, migraines, allergy to shellfish, wasp and bee stings, and latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included AMOXICILLIN, SINGULAIR, MELATONIN, MEDROL, and IODINE, all from unknown dates for unknown indications and unknown if ongoing. The patient previously took LAMICTAL and LATUDA on unknown dates and experienced allergy. On 23Apr2021 at 14:30, the patient experienced swollen tonsils, swollen neck lymph nodes, sore throat, migraines, nerve pain, hard bump at injection site, fatigue, vertigo, nausea, and vomiting. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination the patient had not been tested for COVID-19. The clinical outcome of the events swollen tonsils, swollen neck lymph nodes, sore throat, migraines, nerve pain, hard bump at injection site, fatigue, vertigo, nausea, and vomiting were not resolved at the time of this report.    No follow-up attempts are required, information about lot/batch number cannot be obtained. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Musculoskeletal stiffness, Neck pain
Clinical narrative: Extreme head ache when standing up/sitting down; Neck pain/stiffness; Neck pain/stiffness; This is a spontaneous report from a non-contactable consumer, the patient. A 19-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 18Apr2021 at 15:00 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history included fibro-adipose vascular anomaly (FAVA) lesion that was removed in 2020. It was not known whether the patient had any known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included ibuprofen (MANUFACTURER UNKNOWN) from unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 28Mar at 15:00 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021, the patient experienced extreme head ache when standing up and sitting down and neck pain and stiffness. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme head ache when standing up and sitting down and neck pain and stiffness was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: After the second dose, rash developed on upper left arm where vaccine was given, rash started a day or two after the shot and lasted about a week before it started going away.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 02Apr2021 at 12:45 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included acetylsalicylic acid (ASPIRIN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 12Mar2021 at 12:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. On 03Apr2021, after the second dose, the patient developed rash on upper left arm where vaccine was given, rash started a day or two after the shot and lasted about a week before it started going away. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash on upper left arm where vaccine was given was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Periorbital swelling, Rash pruritic
Clinical narrative: Small amount of puffiness under my left eye; A non-serve fine itchy rash appeared on my face and neck only; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 24Apr2021 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 24Apr2021, around 17:00, a non-serve fine itchy rash appeared on patients face and neck only; with small amount of puffiness under her left eye. The patients temperature had remained around 98.3 degree (units unspecified). Her intake included lots of water. On 25Apr2021, the rash was getting better, but there was some itching. On the day of report the rash and itch was almost gone. Overall, the patient had no other symptoms at anytime. Therapeutic measures were taken as a result of the itchy rash and included hydrocortisone (MANUFACTURER UNKNOWN) cream (reported as generic Hydrocortisone Cream (fast itch and rash relief)). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event a non-serve fine itchy rash appeared on the face and neck only; with small amount of puffiness under her left eye was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Skin lesion, Vaccination site rash
Clinical narrative: Rash at site of injection; Small bumps covering a 2" X 2" area; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Apr2021 at 14:45 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history included sensitive skin, windburn or sunburn resulted in severe rash. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient received any other vaccines within four weeks prior to the COVID-19 vaccine. The patient previously received second dose of Meningitis B (MENINGOCOCCAL VACCINE B) via an unspecified route of administration in the left arm on 19Apr2021 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 09:30, the patient experienced rash at site of injection after receiving 1st dose of Pfizer COVID-19 vaccine and small bumps covering a 2" X 2" area. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of reported events. The clinical outcome of the events rash at site of injection and small bumps covering a 2" X 2" area was recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenopathy, Skin swelling
Clinical narrative: Swollen lymph nodes and pain in armpit.; Swollen lymph nodes and pain in armpit. Swelling under skin on the left hand side of chest  It feels like jello under my skin. Its visible to the naked eye and can feel it when walk and move. On the right side can see my ribs and on the left they are not visible due to this swelling; This is a spontaneous report from a contactable consumer, the patient. A 18-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0161) via an unspecified route of administration in the left arm on 22Apr2021 at 15:00 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW7533) via an unspecified route of administration in the left arm on 01Apr2021 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021, the patient experienced swollen lymph nodes and pain in his armpit. The day after the injection (23Apr2021), he noticed swelling under his skin on the left-hand side of chest. It felt like jello under his skin where it was visible to the naked eye and felt it when walked and moved. On the right side, his ribs were seen and on the left they were not visible due to that swelling. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of the events. The clinical outcome of the events swollen lymph nodes and pain in armpit and swelling under skin on the left-hand side of chest was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Palpitations
Clinical narrative: Experienced only a sore arm until "I" went to bed; "I" had heart palpitations that kept "me" awake; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 25Apr2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history that she was aware of. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 25Apr2021 at 21:30, the patient experienced only a sore arm until she went to bed after the vaccination on Sunday, 25Apr2021 in the morning (as reported). Also, the patient had heart palpitations that kept her awake and feeling fine now on 26Apr2021 (at the time of this report). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events experienced only a sore arm until, went to bed and had heart palpitations that kept her awake was resolved on 26Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: About 2 hours after "I" got the vaccine "I" started getting hives in "my" legs, back, stomach, breasts. Sides, and butt; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 23Apr2021 at 10:30 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 23Apr2021, about 2 hours after the vaccination, the patient started getting hives on her legs, back, stomach, breasts, sides and butt. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event she started getting hives in her legs, back, stomach, breasts. Sides and butt was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Hypoaesthesia, Musculoskeletal stiffness, Peripheral coldness, Swelling
Clinical narrative: Stiffness; Numbness in arm; Swelling; Fingers getting cold; Injection site redness; General weakness; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 26Apr2021 at 10:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol and polycystic ovarian syndrome (PCOS). The patient had no known allergies reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included pravastatin 20 mg (MANUFACTURER UNKNOWN) for unspecified indication on an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FP6955) via an unspecified route of administration in the arm left on 05Apr2021 at 10:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. On 26Apr2021 at 10:45, the patient experienced injection site redness, swelling, numbness in arm, stiffness, fingers getting cold and general weakness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the events injection site redness, swelling, numbness in arm, stiffness, fingers getting cold and general weakness were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Stiffness; Numbness in arm; Swelling; Fingers getting cold; Injection site redness; General weakness; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 26Apr2021 at 10:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol and polycystic ovarian syndrome (PCOS). The patient had no known allergies reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included pravastatin 20 mg (MANUFACTURER UNKNOWN) for unspecified indication on an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FP6955) via an unspecified route of administration in the arm left on 05Apr2021 at 10:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. On 26Apr2021 at 10:45, the patient experienced injection site redness, swelling, numbness in arm, stiffness, fingers getting cold and general weakness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the events injection site redness, swelling, numbness in arm, stiffness, fingers getting cold and general weakness were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Muscular weakness, Myalgia, Pain in extremity, SARS-CoV-2 test
Clinical narrative: Right arm pain got worse and currently have pain from the injection sight down my entire arm; Feels like muscle pain; Weakness throughout my right arm; Makes hard to do daily task and to grasp things with my hand without pain traveling through my arm.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 08Apr2021 at 07:00 (at the age of 41-year-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN) and celecoxib (MANUFACTURER UNKNOWN); all for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FM9809) via an unspecified route of administration in the right arm on 18Mar2021 at 07:00 (at the age of 41-year-old), as a single dose for COVID-19 immunisation. On 11Apr2021, after 3 days of second dose, the patient experienced right arm pain got worse and had pain from the injection sight down entire arm, felt like muscle pain and weakness throughout right arm. The patient reported that, it was hard to do daily task and to grasp things with hand without pain traveling through the arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On 12Apr2021, the patient underwent COVID-19 virus test (via nasal swab) and the result was negative. The clinical outcome of the events right arm pain got worse and had pain from the injection sight down entire arm, felt like muscle pain and weakness throughout right arm, hard to do daily task and to grasp things with hand without pain traveling through the arm was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Dizziness, Fatigue, Muscle tightness, Nausea
Clinical narrative: Starting late 4/16, arm sore and fatigue and dizziness.; Starting late 4/16, arm sore and fatigue and dizziness. Extreme Dizziness / vertigo continued With neck tightness, mild nausea, back ache on and off for 3 days before starting to reduce.; Extreme Dizziness / vertigo continued With neck tightness, mild nausea, back ache on and off for 3 days before starting to reduce.; Extreme Dizziness / vertigo continued With neck tightness, mild nausea, back ache on and off for 3 days before starting to reduce; Extreme Dizziness / vertigo continued With neck tightness, mild nausea, back ache on and off for 3 days before starting to reduce; Extreme Dizziness / vertigo continued With neck tightness, mild nausea, back ache on and off for 3 days before starting to reduce.; Starting late 4/16, arm sore and fatigue and dizziness.; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the arm left on 16Apr2021 at 13:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The medical history included removal of one ovary / fallopian tube due to benign ovarian cyst removal in 2017 and shingles which was activated in 2019. The patient had no illness or chronic health condition. The patient's known allergies were reported as none. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included acetylsalicylic acid (BAYER ASPIRIN) from an unknown date to 14Apr2021 for an unknown indication. The patient previously took varicella zoster vaccine rge (cho)(SHINGRIX) for immunisation since an unknown date. On 16Apr2021 at 21:30, the patient experienced arm sore, fatigue, dizziness. Extreme dizziness/vertigo which was continued with neck tightness, mild nausea and back ache on and off for 3 days before started to reduce. The patient reported that on day 4 (the day of this report) since vaccination, she had occasional dizziness, fatigue, mild nausea and no fever. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm sore, vertigo, neck tightness and back ache on and off were recovering, while the clinical outcome of the events dizziness/extreme dizziness, fatigue and mild nausea were not recovered at the time of this report.    No follow-up attempts are possible. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vertigo
Clinical narrative: Starting late 4/16, arm sore and fatigue and dizziness.; Starting late 4/16, arm sore and fatigue and dizziness. Extreme Dizziness / vertigo continued With neck tightness, mild nausea, back ache on and off for 3 days before starting to reduce.; Extreme Dizziness / vertigo continued With neck tightness, mild nausea, back ache on and off for 3 days before starting to reduce.; Extreme Dizziness / vertigo continued With neck tightness, mild nausea, back ache on and off for 3 days before starting to reduce; Extreme Dizziness / vertigo continued With neck tightness, mild nausea, back ache on and off for 3 days before starting to reduce; Extreme Dizziness / vertigo continued With neck tightness, mild nausea, back ache on and off for 3 days before starting to reduce.; Starting late 4/16, arm sore and fatigue and dizziness.; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the arm left on 16Apr2021 at 13:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The medical history included removal of one ovary / fallopian tube due to benign ovarian cyst removal in 2017 and shingles which was activated in 2019. The patient had no illness or chronic health condition. The patient's known allergies were reported as none. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included acetylsalicylic acid (BAYER ASPIRIN) from an unknown date to 14Apr2021 for an unknown indication. The patient previously took varicella zoster vaccine rge (cho)(SHINGRIX) for immunisation since an unknown date. On 16Apr2021 at 21:30, the patient experienced arm sore, fatigue, dizziness. Extreme dizziness/vertigo which was continued with neck tightness, mild nausea and back ache on and off for 3 days before started to reduce. The patient reported that on day 4 (the day of this report) since vaccination, she had occasional dizziness, fatigue, mild nausea and no fever. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm sore, vertigo, neck tightness and back ache on and off were recovering, while the clinical outcome of the events dizziness/extreme dizziness, fatigue and mild nausea were not recovered at the time of this report.    No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache, Lethargy, Pain in extremity
Clinical narrative: Lethargy; Low energy; Sore arm; Headache; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 23Apr2021 at 16:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies and known allergies to latex, coconut, mango, pineapple. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamin d nos (VIT D) and ethinylestradiol/ norgestimate (MILI) birth control pill, from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 02Apr2021 at 16:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. On 24Apr2021, the patient experienced lethargy, low energy, sore arm and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of reported events. The clinical outcome of the events lethargy, low energy, sore arm and headache was recovered on unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Contusion, Paraesthesia, Vaccination site pain
Clinical narrative: pain at injection site; bruising and tingling all the way down arm to 4th/5th digits.; bruising and tingling all the way down arm to 4th/5th digits.; This is a spontaneous report from a contactable other hcp.    A 64-years-old female Non Pregnant patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection Batch/Lot Number: Unknown), dose 2 other, administered in Arm Right on 22Apr2021 14:30 (Batch/Lot Number: Unknown) as 2nd dose, single for covid-19 immunisation. Medical history included arthritis, drug hypersensitivity. Concomitant medication(s) included ascorbic acid, beta carotene, biotin, calcium, chlorine, chromium, copper, cyanocobalamin, dl-alpha tocopheryl acetate, folic acid, iodine, magnesium, manganese, molybdenum, nickel, nicotinamide, pantothenic acid, phosphorus, phytomenadione, potassium, pyridoxine hydrochloride, retinol, riboflavin, selenium, silicon, thiamine, vanadium, vitamin d nos, xantofyl, zinc (CENTRUM SILVER +50); vitamin e nos (VITAMIN E NOS); vitamin b complex (VITAMIN B COMPLEX); linum usitatissimum seed oil (FLAXSEED OIL NATURE MADE); fish oil (FISH OIL); slippery elm (SLIPPERY ELM); magnesium (MAGNESIUM). The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID. It was Reported that, on 22Apr2021 Patient received second COVID-19 vaccine dose injection below deltoid muscle. Within a few hours developed pain at injection site, bruising and tingling all the way down arm to 4th/5th digits with outcome of recovering.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product administered at inappropriate site, Skin discolouration, Vaccination site erythema, Vaccination site pain
Clinical narrative: pain at injection site; bruising and tingling all the way down arm to 4th/5th digits.; bruising and tingling all the way down arm to 4th/5th digits.; This is a spontaneous report from a contactable other hcp.    A 64-years-old female Non Pregnant patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection Batch/Lot Number: Unknown), dose 2 other, administered in Arm Right on 22Apr2021 14:30 (Batch/Lot Number: Unknown) as 2nd dose, single for covid-19 immunisation. Medical history included arthritis, drug hypersensitivity. Concomitant medication(s) included ascorbic acid, beta carotene, biotin, calcium, chlorine, chromium, copper, cyanocobalamin, dl-alpha tocopheryl acetate, folic acid, iodine, magnesium, manganese, molybdenum, nickel, nicotinamide, pantothenic acid, phosphorus, phytomenadione, potassium, pyridoxine hydrochloride, retinol, riboflavin, selenium, silicon, thiamine, vanadium, vitamin d nos, xantofyl, zinc (CENTRUM SILVER +50); vitamin e nos (VITAMIN E NOS); vitamin b complex (VITAMIN B COMPLEX); linum usitatissimum seed oil (FLAXSEED OIL NATURE MADE); fish oil (FISH OIL); slippery elm (SLIPPERY ELM); magnesium (MAGNESIUM). The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID. It was Reported that, on 22Apr2021 Patient received second COVID-19 vaccine dose injection below deltoid muscle. Within a few hours developed pain at injection site, bruising and tingling all the way down arm to 4th/5th digits with outcome of recovering.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Contusion, Paraesthesia, Vaccination site pain
Clinical narrative: Received shot in bi-cep instead of where it was suppose to be administered; Black and blue arm; Red in large area around shot; Soreness in large area around shot; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 22Apr2021 at 14:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin and bandaids. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ascorbic acid, pyridoxine hydrochloride, biotin, folic acid, colecalciferol, retinol, pantothenic acid, riboflavin, phytomenadione, nicotinamide, betacarotene, iron, magnesium, manganese, potassium, chromium, copper, zinc, calcium, iodine, phosphorus, selenium, vitamin B12 nos, xantofyl, lycopene, vitamin B1 nos, vitamin E nos (CENTRUM SILVER); calcium (MANUFACTURER UNKNOWN); cynara cardunculus, malus spp. vinegar extract, taraxacum officinale (APPLE CIDER) and black elder (MANUFACTURER UNKNOWN), all taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received bacitracin, neomycin sulfate, polymyxin B sulfate (MYCITRACIN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on unknown date in Apr2021 at 14:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 14:30, the patient reported that he had received shot in bi-cep instead of where it was supposed to be administered and experienced black and blue arm and red soreness in large area around shot. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events received shot in bi-cep, black and blue arm and red soreness in large area around shot was recovering at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product administered at inappropriate site, Skin discolouration, Vaccination site erythema, Vaccination site pain
Clinical narrative: Received shot in bi-cep instead of where it was suppose to be administered; Black and blue arm; Red in large area around shot; Soreness in large area around shot; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 22Apr2021 at 14:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin and bandaids. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ascorbic acid, pyridoxine hydrochloride, biotin, folic acid, colecalciferol, retinol, pantothenic acid, riboflavin, phytomenadione, nicotinamide, betacarotene, iron, magnesium, manganese, potassium, chromium, copper, zinc, calcium, iodine, phosphorus, selenium, vitamin B12 nos, xantofyl, lycopene, vitamin B1 nos, vitamin E nos (CENTRUM SILVER); calcium (MANUFACTURER UNKNOWN); cynara cardunculus, malus spp. vinegar extract, taraxacum officinale (APPLE CIDER) and black elder (MANUFACTURER UNKNOWN), all taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received bacitracin, neomycin sulfate, polymyxin B sulfate (MYCITRACIN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on unknown date in Apr2021 at 14:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 14:30, the patient reported that he had received shot in bi-cep instead of where it was supposed to be administered and experienced black and blue arm and red soreness in large area around shot. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events received shot in bi-cep, black and blue arm and red soreness in large area around shot was recovering at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Nose bleed; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm left on 25Apr2021 at 15:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included Lyme disease diagnosed 8 years ago in 2013. The patient did not have any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication was not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccination. On 26Apr2021 at 9:30, the patient experienced nose bleed which lasted for 1 hour. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event nose bleed was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Fatigue
Clinical narrative: Chest pain on left side under ribs; Fatigued; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 20Apr2021 at 13:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient reported allergies as not applicable. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in left arm on 27Mar2021 at 14:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 17:00, 27 hours after second dose of vaccination, the patient experienced chest pain on left side under ribs and was also fatigued. Chest pain lasted 3 or so hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chest pain on left side under ribs and fatigued was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Stomatitis
Clinical narrative: Mouth Sores; Swollen Lymph Nodes; This is a spontaneous report from a contactable healthcare professional. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 24Apr2021 at 10:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 24Apr2021 at 23:00, the patient experienced mouth sores and swollen lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mouth sores and swollen lymph nodes was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Angular cheilitis
Clinical narrative: Angular cheilitis on both corners of "my" lips; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on an unknown date in Apr2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. On 19Apr2021, approximately 2-3 days after receiving the second dose, the patient suddenly had angular cheilitis on both corners of his lips. The patient never had this occur before in his life. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event angular cheilitis on both corners of "my" lips was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.